News From CHADD Volume 3, Number 56 October 21, 2003 PRESIDENT’S BIOETHICS COUNCIL AFFIRMS MULTIMODAL TREATMENT FOR AD/HD Multiple Concerns Raised About Medication Use On Thursday, October 16, the President’s Council on Bioethics issued a 320-page report examining the ethical and social implications of using biotechnology on… Read more »

FRED A. BAUGHMAN, JR. M.D. NEUROLOGY AND CHILD NEUROLOGY (Board Certified) FELLOW, AMERICAN ACADEMY OF NEUROLOGY fredbaughmanmd@cox.net 1303 HIDDEN MOUNTAIN DRIVE EL CAJON, CA 92019 � Tele:(619) 440-8236                                                                                                Fax: (619) 442-1932 �… Read more »

The Canberra Times, Friday, March 19, 2004 Medication backed to treat blues By Danielle Cronin, Health Reporter Canberra academics have defended the use of drugs to treat depression after a visiting psychologist challenged the popular practice. Dr. Dorothy Rowe, who has penned books on depression and was… Read more »

The Scientist 18/03/04 http://www.biomedcentral.com/news/20040318/03 FDA announces reform plans Agency hopes to reduce development costs by using diagnostic and imaging technologies | By Paula Park The Food and Drug Administration (FDA), citing a gap between investment in pharmaceutical research and new drug approvals, announced plans Tuesday (March 16) to reform… Read more »

Neuroimaging & GSK http://www.biomedcentral.com/news/20040316/04 Imaging center planned in London Imperial College and GlaxoSmithKline to jointly fund a new facility for 400 staff By Linda Nordling Plans to build a £76 million medical imaging research center in London were unveiled on Tuesday (March 16) by Imperial College London… Read more »